Gabrielle Lapping-Carr
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gabrielle Lapping-Carr has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Eric C. Beyer
Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA
6 shared publications Radhika Peddinti
The University of Chicago Medicine, Chicago, IL
4 shared publications- Joanna Gemel
Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA
3 shared publications - Yifan Mao
Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA
3 shared publications Gianna Sparks
Department of Pediatrics, University of Chicago, Chicago, USA
2 shared publicationsJoanna Gemel
Department of Pediatrics, University of Chicago, Chicago, USA
2 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3 (3)
Impaired Cellular Trafficking of a Novel Thrombomodulin Mutant Causes Severe Bleeding, Thrombosis, and Atypical HUS
- 19 June 2026
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 3 (3)
Open AccessImpaired Cellular Trafficking of a Novel Thrombomodulin Mutant Causes Severe Bleeding, Thrombosis, and Atypical HUS
- Open Access
- 13 June 2025
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (12) , 2970-2979
Triaging acute chest syndrome clinical decision-making using bedside SaO2/FiO2 ratio
Acute chest syndrome (ACS) severity is inconsistently defined, and its clinical course is difficult to predict. This retrospective observational study evaluated the utility of the ratio of pulse oximetry oxygen saturation (SaO2) to the fraction of inspired oxygen (SaO2/FiO2) in adult patients with ACS and its association with the clinical outcome of intensive care unit (ICU) transfer. Across all ACS hospitalizations at a tertiary medical center from 2017 to 2021, we characterized the SaO2/FiO2 ratio at 3 time points: emergency department (ED) presentation, ACS diagnosis, and antibiotic initiation. Of the 227 hospitalizations identified, 54% were female, the mean age was 29 years, 70% had hemoglobin SS, and 9% had obesity. Although ICU transfer was not strongly associated with the SaO2/FiO2 ratio at ED presentation (area under the curve [AUC], 0.59), it was strongly associated with the ratio at ACS diagnosis (AUC, 0.73) and antibiotic initiation (AUC, 0.74). Given the highest sensitivity at ACS diagnosis, a diagnostic SaO2/FiO2 cutoff of 310 was proposed for triaging likely ICU transfer (sensitivity, 63%; specificity, 82%; adjusted odds ratio, 8.94; 95% confidence interval [CI], 2.12-37.6; adjusted hazard ratio, 4.86; 95% CI, 1.91-12.4), with models adjusted for obesity, lung disease, and blood counts. This cutoff corresponds to an SaO2 acquired from pulse oximeter saturation <90% on 2 L/min nasal cannula support. We propose using the SaO2/FiO2 ratio cutoff of 310 prospectively as a simple bedside triage tool for adult patients with sickle cell disease hospitalized with ACS to be transferred to a higher level of care.
- 13 June 2025
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (12) , 2970-2979
Open AccessTriaging acute chest syndrome clinical decision-making using bedside SaO2/FiO2 ratio
Acute chest syndrome (ACS) severity is inconsistently defined, and its clinical course is difficult to predict. This retrospective observational study evaluated the utility of the ratio of pulse oximetry oxygen saturation (SaO2) to the fraction of inspired oxygen (SaO2/FiO2) in adult patients with ACS and its association with the clinical outcome of intensive care unit (ICU) transfer. Across all ACS hospitalizations at a tertiary medical center from 2017 to 2021, we characterized the SaO2/FiO2 ratio at 3 time points: emergency department (ED) presentation, ACS diagnosis, and antibiotic initiation. Of the 227 hospitalizations identified, 54% were female, the mean age was 29 years, 70% had hemoglobin SS, and 9% had obesity. Although ICU transfer was not strongly associated with the SaO2/FiO2 ratio at ED presentation (area under the curve [AUC], 0.59), it was strongly associated with the ratio at ACS diagnosis (AUC, 0.73) and antibiotic initiation (AUC, 0.74). Given the highest sensitivity at ACS diagnosis, a diagnostic SaO2/FiO2 cutoff of 310 was proposed for triaging likely ICU transfer (sensitivity, 63%; specificity, 82%; adjusted odds ratio, 8.94; 95% confidence interval [CI], 2.12-37.6; adjusted hazard ratio, 4.86; 95% CI, 1.91-12.4), with models adjusted for obesity, lung disease, and blood counts. This cutoff corresponds to an SaO2 acquired from pulse oximeter saturation <90% on 2 L/min nasal cannula support. We propose using the SaO2/FiO2 ratio cutoff of 310 prospectively as a simple bedside triage tool for adult patients with sickle cell disease hospitalized with ACS to be transferred to a higher level of care.
- Open Access
- 18 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (8) , 3831
Plasma Levels of MicroRNA Let-7c-5p May Predict Risk of Acute Chest Syndrome in Patients with Sickle Cell Disease
Acute chest syndrome (ACS) is among the most serious complications of sickle cell disease (SCD). While the pathogenesis of ACS is incompletely understood, endothelial damage and microvascular occlusion are critical components. Our previous studies have implicated small extracellular vesicles in the plasma of subjects with SCD in causing endothelial dysfunction. This suggested that microRNAs within these small EVs might be responsible for endothelial damage. The sequencing of microRNAs in small EVs from the plasma of subjects with SCD revealed that several miRNAs were differentially expressed between subjects with and without ACS history, including let-7c-5p. In a replication cohort, plasma let-7c-5p levels were quantified via RT-qPCR. The baseline plasma let-7c-5p level was twofold higher in patients without previous ACS. Furthermore, we observed a positive correlation between let-7c-5p levels and time to subsequent ACS events. These findings suggest a role for let-7c-5p in endothelial disruption underlying ACS pathogenesis. It may also serve as a novel biomarker for ACS detection and the prediction of disease progression.
- 18 April 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (8) , 3831
Open AccessPlasma Levels of MicroRNA Let-7c-5p May Predict Risk of Acute Chest Syndrome in Patients with Sickle Cell Disease
Acute chest syndrome (ACS) is among the most serious complications of sickle cell disease (SCD). While the pathogenesis of ACS is incompletely understood, endothelial damage and microvascular occlusion are critical components. Our previous studies have implicated small extracellular vesicles in the plasma of subjects with SCD in causing endothelial dysfunction. This suggested that microRNAs within these small EVs might be responsible for endothelial damage. The sequencing of microRNAs in small EVs from the plasma of subjects with SCD revealed that several miRNAs were differentially expressed between subjects with and without ACS history, including let-7c-5p. In a replication cohort, plasma let-7c-5p levels were quantified via RT-qPCR. The baseline plasma let-7c-5p level was twofold higher in patients without previous ACS. Furthermore, we observed a positive correlation between let-7c-5p levels and time to subsequent ACS events. These findings suggest a role for let-7c-5p in endothelial disruption underlying ACS pathogenesis. It may also serve as a novel biomarker for ACS detection and the prediction of disease progression.
- Open Access
- 15 November 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (Supplement) , 8218-8219
Area of Residence As a Screening Tool for Sickle Cell Disease Outcomes in Chicago Pediatric Patients
Background: Sickle cell disease (SCD) is a chronic condition that, in the United States, largely affects a socioeconomically vulnerable group of patients. We ha
- 15 November 2022
- Published by American Society of Hematology in Blood
- Vol. 140 (Supplement) , 8218-8219
Open AccessArea of Residence As a Screening Tool for Sickle Cell Disease Outcomes in Chicago Pediatric Patients
Background: Sickle cell disease (SCD) is a chronic condition that, in the United States, largely affects a socioeconomically vulnerable group of patients. We ha
- Open Access
- 3 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 816
Circulating Small Extracellular Vesicles May Contribute to Vaso-Occlusive Crises in Sickle Cell Disease
We previously found that the plasma of patients with sickle cell disease (SCD) contains large numbers of small extracellular vesicles (EVs) and that the EVs disrupt the integrity of endothelial cell monolayers (especially if obtained during episodes of acute chest syndrome, ACS). The present study was designed to test the generality of this finding to other complications of SCD, specifically to evaluate the possibility that circulating EVs isolated during a vaso-occlusive crises (VOC) also cause damage to the intercellular connections between endothelial cells. Plasma was obtained from nine pediatric subjects at baseline and during VOC episodes. EVs isolated from these samples were added to cultures of microvascular endothelial cells. Immunofluorescence microscopy was employed to assess monolayer integrity and to localize two intercellular junction proteins (VE-cadherin and connexin43). The EVs isolated during VOC caused significantly greater monolayer disruption than those isolated at baseline. The extent of disruption varied between different episodes of VOC or ACS in the same patient. The VOC EVs disrupted the integrity of both junction proteins at appositional membranes. These results suggest that circulating EVs may be involved in modulating endothelial integrity contributing to the pathogenesis of different complications of SCD.
- 3 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 816
Open AccessCirculating Small Extracellular Vesicles May Contribute to Vaso-Occlusive Crises in Sickle Cell Disease
We previously found that the plasma of patients with sickle cell disease (SCD) contains large numbers of small extracellular vesicles (EVs) and that the EVs disrupt the integrity of endothelial cell monolayers (especially if obtained during episodes of acute chest syndrome, ACS). The present study was designed to test the generality of this finding to other complications of SCD, specifically to evaluate the possibility that circulating EVs isolated during a vaso-occlusive crises (VOC) also cause damage to the intercellular connections between endothelial cells. Plasma was obtained from nine pediatric subjects at baseline and during VOC episodes. EVs isolated from these samples were added to cultures of microvascular endothelial cells. Immunofluorescence microscopy was employed to assess monolayer integrity and to localize two intercellular junction proteins (VE-cadherin and connexin43). The EVs isolated during VOC caused significantly greater monolayer disruption than those isolated at baseline. The extent of disruption varied between different episodes of VOC or ACS in the same patient. The VOC EVs disrupted the integrity of both junction proteins at appositional membranes. These results suggest that circulating EVs may be involved in modulating endothelial integrity contributing to the pathogenesis of different complications of SCD.
- 31 March 2021
- Published by Springer Nature in Pediatric Research
- Vol. 89 (4) , 1036
Insights image for “Circulating extracellular vesicles from patients with acute chest syndrome disrupt adherens junctions between endothelial cells”
- 31 March 2021
- Published by Springer Nature in Pediatric Research
- Vol. 89 (4) , 1036
Insights image for “Circulating extracellular vesicles from patients with acute chest syndrome disrupt adherens junctions between endothelial cells”
- Open Access
- 24 November 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (23) , 8884
Gap Junctions between Endothelial Cells Are Disrupted by Circulating Extracellular Vesicles from Sickle Cell Patients with Acute Chest Syndrome
Intercellular junctions maintain the integrity of the endothelium. We previously found that the adherens and tight junctions between endothelial cells are disrupted by plasma extracellular vesicles from patients with sickle cell disease (especially those with Acute Chest Syndrome). In the current study, we evaluated the effects of these vesicles on endothelial gap junctions. The vesicles from sickle cell patients (isolated during episodes of Acute Chest Syndrome) disrupted gap junction structures earlier and more severely than the other classes of intercellular junctions (as detected by immunofluorescence). These vesicles were much more potent than those isolated at baseline from the same subject. The treatment of endothelial cells with these vesicles led to reduced levels of connexin43 mRNA and protein. These vesicles severely reduced intercellular communication (transfer of microinjected Neurobiotin). Our data suggest a hierarchy of progressive disruption of different intercellular connections between endothelial cells by circulating extracellular vesicles that may contribute to the pathophysiology of the endothelial disturbances in sickle cell disease.
- 24 November 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (23) , 8884
Open AccessGap Junctions between Endothelial Cells Are Disrupted by Circulating Extracellular Vesicles from Sickle Cell Patients with Acute Chest Syndrome
Intercellular junctions maintain the integrity of the endothelium. We previously found that the adherens and tight junctions between endothelial cells are disrupted by plasma extracellular vesicles from patients with sickle cell disease (especially those with Acute Chest Syndrome). In the current study, we evaluated the effects of these vesicles on endothelial gap junctions. The vesicles from sickle cell patients (isolated during episodes of Acute Chest Syndrome) disrupted gap junction structures earlier and more severely than the other classes of intercellular junctions (as detected by immunofluorescence). These vesicles were much more potent than those isolated at baseline from the same subject. The treatment of endothelial cells with these vesicles led to reduced levels of connexin43 mRNA and protein. These vesicles severely reduced intercellular communication (transfer of microinjected Neurobiotin). Our data suggest a hierarchy of progressive disruption of different intercellular connections between endothelial cells by circulating extracellular vesicles that may contribute to the pathophysiology of the endothelial disturbances in sickle cell disease.
- 26 May 2020
- Published by Springer Nature in Pediatric Research
- Vol. 89 (4) , 776-784
Circulating extracellular vesicles from patients with acute chest syndrome disrupt adherens junctions between endothelial cells
Background Small cell-derived extracellular vesicles (EVs) can affect endothelial function. We previously found that patients with sickle cell disease (SCD) have greater numbers of circulating EVs than subjects without the disease, and the EVs differentially disrupt endothelial integrity in vitro. Because endothelial disruption is a critical component of acute chest syndrome (ACS), we hypothesized that EVs isolated during ACS would induce greater endothelial damage than those isolated at baseline. Methods Nine pediatric subjects had plasma isolated at baseline and during ACS from which EVs were isolated. Cultured microvascular endothelial cells were treated with EVs and then studied by immunofluorescence microscopy to localize VE-cadherin and F-actin. Results The EVs had a diameter of 95 nm. They contained CD63 and flotillin-1, which were increased in SCD patients (5–13-fold compared to control) and further increased between baseline and ACS (24–57%). The EVs contained hemoglobin, glycophorin A, and ferritin. Treatment with baseline EVs caused modest separation of endothelial cells, while ACS EVs caused substantial disruptions of the endothelial cell monolayers. EVs from subjects with ACS also caused a 50% decrease in protein levels of VE-cadherin. Conclusions These results suggest that circulating EVs can modulate endothelial integrity contributing to the development of ACS in SCD patients by altering cadherin-containing intercellular junctions. Impact Sickle cell disease patients have circulating extracellular vesicles (EVs) that modulate endothelial integrity by altering cadherin-containing intercellular junctions. Disruption is more severe by EVs obtained during acute chest syndrome (ACS). These results expand our knowledge of the pathophysiology of acute chest syndrome and the vasculopathies of sickle cell disease.
- 26 May 2020
- Published by Springer Nature in Pediatric Research
- Vol. 89 (4) , 776-784
Circulating extracellular vesicles from patients with acute chest syndrome disrupt adherens junctions between endothelial cells
Background Small cell-derived extracellular vesicles (EVs) can affect endothelial function. We previously found that patients with sickle cell disease (SCD) have greater numbers of circulating EVs than subjects without the disease, and the EVs differentially disrupt endothelial integrity in vitro. Because endothelial disruption is a critical component of acute chest syndrome (ACS), we hypothesized that EVs isolated during ACS would induce greater endothelial damage than those isolated at baseline. Methods Nine pediatric subjects had plasma isolated at baseline and during ACS from which EVs were isolated. Cultured microvascular endothelial cells were treated with EVs and then studied by immunofluorescence microscopy to localize VE-cadherin and F-actin. Results The EVs had a diameter of 95 nm. They contained CD63 and flotillin-1, which were increased in SCD patients (5–13-fold compared to control) and further increased between baseline and ACS (24–57%). The EVs contained hemoglobin, glycophorin A, and ferritin. Treatment with baseline EVs caused modest separation of endothelial cells, while ACS EVs caused substantial disruptions of the endothelial cell monolayers. EVs from subjects with ACS also caused a 50% decrease in protein levels of VE-cadherin. Conclusions These results suggest that circulating EVs can modulate endothelial integrity contributing to the development of ACS in SCD patients by altering cadherin-containing intercellular junctions. Impact Sickle cell disease patients have circulating extracellular vesicles (EVs) that modulate endothelial integrity by altering cadherin-containing intercellular junctions. Disruption is more severe by EVs obtained during acute chest syndrome (ACS). These results expand our knowledge of the pathophysiology of acute chest syndrome and the vasculopathies of sickle cell disease.
- 9 May 2017
- Published by Wiley in Pediatric Pulmonology
- Vol. 52 (11) , 1478-1485
Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings
Background: Acute Chest Syndrome (ACS) is one of the leading causes of death among children with Sickle Cell Disease (SCD). Disruption of microvascular integrity is critical to the pathophysiology of ACS, but the factors governing its phenotypic variability are incompletely understood. Because circulating exosomes have been implicated in vascular dysfunction in various diseases, we hypothesized that exosomes induce endothelial dysfunction in patients who experience ACS.Procedure: Cross‐sectional cohort study including 33 outpatients with SCD (without new health‐related complaints or recent transfusions) and a cohort of control patients. Exosomes were isolated from platelet‐free plasma.Results: ImageStream showed that exosome counts were greatly increased in patients with SCD compared with controls, but there were few differences in the concentrations of exosomes between patients who had experienced ACS (ACS(+)) and those who had not (ACS(−)). Exosomes were added to human microvascular endothelial cells, and the exosomal effects on monolayer integrity was determined using Electric Cell‐substrate Impedance Sensing (ECIS). Exosomes from SCD patients without ACS differed minimally from control patients; however, exosomes from ACS(+) decreased endothelial cell resistance compared to ACS(−), (Relative resistance: ACS(+): 0.981 ± 0.055 vs ACS(−): 1.124 ± 0.042; P = 0.006). Treatment of endothelial cultures with exosomes from ACS(−) patients increased endothelial Nitric Oxide Synthase (eNOS) mRNA expression, while ACS(+)‐derived exosomes were not able to increase eNOS expression above that of controls.Conclusions: These findings demonstrate that patients with SCD have circulating exosomes that produce differential effects that may contribute to the pathophysiology of ACS and may serve as risk‐related biomarkers.
- 9 May 2017
- Published by Wiley in Pediatric Pulmonology
- Vol. 52 (11) , 1478-1485
Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings
Background: Acute Chest Syndrome (ACS) is one of the leading causes of death among children with Sickle Cell Disease (SCD). Disruption of microvascular integrity is critical to the pathophysiology of ACS, but the factors governing its phenotypic variability are incompletely understood. Because circulating exosomes have been implicated in vascular dysfunction in various diseases, we hypothesized that exosomes induce endothelial dysfunction in patients who experience ACS.Procedure: Cross‐sectional cohort study including 33 outpatients with SCD (without new health‐related complaints or recent transfusions) and a cohort of control patients. Exosomes were isolated from platelet‐free plasma.Results: ImageStream showed that exosome counts were greatly increased in patients with SCD compared with controls, but there were few differences in the concentrations of exosomes between patients who had experienced ACS (ACS(+)) and those who had not (ACS(−)). Exosomes were added to human microvascular endothelial cells, and the exosomal effects on monolayer integrity was determined using Electric Cell‐substrate Impedance Sensing (ECIS). Exosomes from SCD patients without ACS differed minimally from control patients; however, exosomes from ACS(+) decreased endothelial cell resistance compared to ACS(−), (Relative resistance: ACS(+): 0.981 ± 0.055 vs ACS(−): 1.124 ± 0.042; P = 0.006). Treatment of endothelial cultures with exosomes from ACS(−) patients increased endothelial Nitric Oxide Synthase (eNOS) mRNA expression, while ACS(+)‐derived exosomes were not able to increase eNOS expression above that of controls.Conclusions: These findings demonstrate that patients with SCD have circulating exosomes that produce differential effects that may contribute to the pathophysiology of ACS and may serve as risk‐related biomarkers.
- Open Access
- 15 June 2015
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 191 (12) , 1459-1461
Insights into Selected Aspects of Pediatric Sleep Medicine
- 15 June 2015
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 191 (12) , 1459-1461
Open AccessInsights into Selected Aspects of Pediatric Sleep Medicine